BFS
HUMA icon

Burkett Financial Services’s Humacyte HUMA Stock Holding History

Burkett Financial Services’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-18
Closed -$10 – 273
2026
Q1 		$10 Hold
18
– – ﹤0.01% 248
2025
Q4 		$17 Hold
18
– – ﹤0.01% 234
2025
Q3 		$31 Hold
18
– – ﹤0.01% 221
2025
Q2 		$38 Hold
18
– – ﹤0.01% 224
2025
Q1 		$31 Hold
18
– – ﹤0.01% 250
2024
Q4 		$91 Hold
18
– – ﹤0.01% 216
2024
Q3 		$98 Hold
18
– – ﹤0.01% 211
2024
Q2 		$86 Buy
+18
New +$94 ﹤0.01% 193

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Burkett Financial Services's HUMA Position: Q2 2026 in Review

Burkett Financial Services sold out of Humacyte (HUMA) in Q2 2026, closing a stake of 18 shares — an estimated $10 sold.

Burkett Financial Services first reported a position in HUMA in Q2 2024 and held it in 8 quarters. The position peaked at $98 in Q3 2024. 164 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Burkett Financial Services reported no remaining Humacyte position as of Q2 2026 after selling out during the quarter.
  • Burkett Financial Services sold 18 Humacyte shares in Q2 2026, an estimated $10.
  • Burkett Financial Services first reported a position in Humacyte in Q2 2024 and held it in 8 quarters.
  • Burkett Financial Services's Humacyte position peaked at $98 in Q3 2024.
  • 164 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Burkett Financial Services's 13F filing for Q2 2026, filed 2 Jul 2026.